Skip to main content

Table 2 Levels of SETD2 mRNA expression (After CK19 normalisation) in each group of patients

From: The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters

Parameter subgroups No. Median Mean ± SD
All samples SETD2 all tissue 153 27 85547 ± 498012
  Normal tissue 33 406 414434 ± 1106629
  Tumor tissue 120 17 20950 ± 37626
NPI NPI1 68 11 8755 ± 26203
  NPI2 37 24 16517 ± 55868
  NPI3 15 3 318 ± 645
Grade Grade1 23 3 2592 ± 9686
  Grade2 41 19 11942 ± 35360
  Grade3 56 26 11457 ± 44706
TNM staging TNM1 69 4 8551 ± 29766
  TNM2 40 42 8578 ± 24043
  TNM3 7 0 174 ± 414
  TNM4 4 221 679 ± 1081
Clinical outcomes Disease free 81 13 12239 ± 43466
  Alive with Metastasis 7 2 1983 ± 5142
  Local recurrence 5 930 3513 ± 5683
  Died of Br Ca 20 16 698 ± 1741
ER receptor status ERą negative 7 24 4742 ± 18706
  ERą positive 26 41 14278 ± 46482
  ERβ negative 62 6 1698 ± 4441
  ERβ positive 17 27 13353 ± 43908